Trends in non-pharmacological treatment for insomnia: A nationwide study.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 41202023.
- Also identified by DOI 10.1371/journal.pone.0334142 and PMC identifier 12594322.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
As the prevalence of insomnia disorder in Korea is gradually increasing, understanding real-world treatment patterns is essential for designing appropriate clinical guidelines. Although non-pharmacological treatments are recommended as first-line interventions, their actual use in clinical settings remains insufficiently studied. This study examined the current status of non-pharmacological treatments for insomnia implemented by Korean doctors. Data from the National Health Insurance Service (NHIS) sample cohort, comprising 518,119 patients diagnosed with insomnia disorder (ICD-10 code: G47) between 2002 and 2019, were analyzed. Treatment types at the time of first diagnosis and the timing of non-pharmacological treatment initiation were assessed. Only 0.01% of patients received non-pharmacological treatment at their first diagnosis, and 97.5% did not receive such treatment during the study period. Among those who eventually received it, the interval from diagnosis to treatment initiation decreased over time. A modest increase in the use of non-pharmacological treatments was observed after 2018, following changes in national insurance coverage. The findings highlight a significant gap between clinical guidelines and real-world practice. Although non-pharmacological treatments remain underutilized, recent improvements suggest potential for better integration into routine care, emphasizing the need for ongoing efforts to enhance access to recommended therapies.
Medical subject headings
- Sleep Initiation and Maintenance Disorders